High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN)

Next Previous
Trial Profile

High Risk Neuroblastoma Study 1 of SIOP-Europe (SIOPEN)

Recruiting
Phase of Trial: Phase III

Latest Information Update: 03 Oct 2016

At a glance

  • Drugs Aldesleukin (Primary) ; Etoposide (Primary) ; Busulfan; Carboplatin; Cisplatin; Cyclophosphamide; Doxorubicin; Filgrastim; Melphalan; Vincristine
  • Indications Neuroblastoma
  • Focus Therapeutic Use

    • Most Recent Events

    • 26 Sep 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2017.
    • 26 Sep 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.
    • 20 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top